MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2017 International Congress

    The non-motor symptoms in Parkinsons’s disease patients treated with STN DBS: the follow up study

    M. Mencinger, M. Červek, T. Rus, G. Jakob, D. Georgiev, D. Flisar, R. Rajnar, M. Benedičič, K. Boetzel, J. Mehrkens, Z. Pirtošek, M. Trošt (Ljubljana, Slovenia)

    Objective: The aim of the study was to follow-up the effect of STN DBS on motor and non-motor symptoms in aPD.  Background: A comprehensive assessment…
  • 2017 International Congress

    Improving Nursing Education on the care of those with Parkinson’s disease

    G. Vernon (Philadelphia, PA, USA)

    Objective: The Edmond J. Safra Visiting Nurse Faculty Program at the Parkinson's DIsease Foundation provides a 40 contact hour accredited course for nursing faculty by linking…
  • 2017 International Congress

    Reproducibility of data-driven Parkinson’s disease subtypes for clinical research using a Delphi process for expert-based consensus.

    T. Mestre, S. Eberly, C. Tanner, A. Lang, D. Grimes, D. Oakes, C. Marras (Ottawa, ON, Canada)

    Objective: To assess reproducibility of published data-driven PD subtype classification systems. Background: There is no consensus on which is the most robust PD subtype classification…
  • 2017 International Congress

    Exposure to bifenthrin contributes to Parkinson’s disease in mouse model

    C. Han, S. Liu, J. Huang, L. Liu, K. Ma, X. Guo, S. Guo, L. Wang, Y. Shen, Y. Xia, F. Wan, N. Xiong, T. Wang (Wuhan, China)

    Objective: To explore the relationship between pyrethroid bifenthrin and Parkinson’s disease on mouse model. Background: Pyrethroid is now widely used on account of its high…
  • 2017 International Congress

    Spg 11 gene mutation associated autosomal recessive hereditary spastic paraplegia presenting with partially levodopa responsive parkinsonism, stereotypy and cognitive decline.

    S. Desai, S. Singh, V. Patel, J. Sheth (Anand, India)

    Objective: To describe a rare case of SPG11 gene mutation associated complex hereditary spastic paraplegia with partially levodopa responsive parkinsonism Background: Hereditary Spastic Paraplegia (HSP)…
  • 2017 International Congress

    Patient Clustering through a Mobile-based PD Severity Score

    A. Zhan, S. Mohan, M. Elson, E. Dorsey, A. Terzis, S. Saria (Baltimore, MD, USA)

    Objective: To demonstrate that PD patients can be clustered based on their performance on smartphone-enabled active tests. Background: Treatment decisions of PD require granular information…
  • 2017 International Congress

    Co-speech gestures in Parkinson’s disease (PD)

    M. Bacigalupe (La Plata, Argentina)

    Objective: We develop an analytical description of co-speech gesture production in PD patients. Background: Communication and expressive behavior problems are frequent in PD patients (Duncan…
  • 2017 International Congress

    Semi-automated MRI algorithm using susceptibility weighted imaging for differentiating multiple system atrophy with parkinsonism from Parkinson Disease

    W.-W. Lee, H.-J. Kim, C.-H. Sohn, H. Park, B. Jeon (Seoul, Republic of Korea)

    Objective: To investigate the diagnostic value of semi-automated diagnostic algorithm using 3T-MR susceptibility-weighted image (SWI) for multiple system atrophy with parkinsonism (MSA-p). Background: Iron deposition…
  • 2017 International Congress

    High systolic blood pressure is associated with cognitive impairment in Parkinson’s disease (PD)

    H. Chan, Y. Cheung, T. Fung, A. Leung, W. Fong (Hong Kong, Hong Kong)

    Objective: To assess if metabolic risk factors are associated with cognitive dysfunction in PD patients. Background: Metabolic syndrome is known as a risk factor of many…
  • 2017 International Congress

    Depression and Cognitive Performance in Patients with Parkinson’s Disease

    A.J. Jacob, S. OJ, S. K, G. Kumarpillai (Bangalore, India)

    Objective: The aim of this study was to assess the relationship between  depression on cognitive performance in Parkinson’s disease  patients.  Background: There are very few…
  • « Previous Page
  • 1
  • …
  • 317
  • 318
  • 319
  • 320
  • 321
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley